Canigen L4

1 x 10 dose
Suspension for injection
SC

Species

Dogs.

Indications

For active immunisation of dogs against:

- L. interrogans serogroup Canicola serovar Canicola to reduce infection and urinary excretion

- L. interrogans serogroup Icterohaemorrhagiae serovar Copenhageni to reduce infection and urinary excretion

- L. interrogans serogroup Australis serovar Bratislava to reduce infection

- L. kirschneri serogroup Grippotyphosa serovar Bananal/Lianguang to reduce infection and urinary excretion

Onset of immunity: 3 weeks.

Duration of immunity: 1 year.

Dose to be administered and administration route

Subcutaneous use.

Before use, ensure that the vaccine is at room temperature (15 °C – 25 °C).

Administer two vaccinations of 1 dose (1 ml) of vaccine with an interval of 4 weeks to dogs from 6 weeks of age onwards.

Vaccination schedule:

Primary vaccination:

The first vaccination can be administered from 6 to 9(*) weeks of age and the second vaccination from 10 to 13 weeks of age.

Revaccination:

Dogs should be re-vaccinated annually with one dose (1 ml) of vaccine.

(*) In case of high level of maternally derived antibodies, first vaccination is recommended at 9 weeks of age.

For simultaneous use, 1 dose of a Canigen vaccine containing canine distemper virus, canine adenovirus type 2, canine parvovirus (strain 154) and/or canine parainfluenza virus components should be reconstituted with 1 dose (1 ml) of this vaccine. The mixed vaccines should be at room temperature (15 °C – 25 °C) before they are administered by subcutaneous injection.

Adverse reactions

Dogs:

Very common

(>1 animal / 10 animals treated):

Injection site swelling[1],

Injection site nodule1,

Injection site pain[2],

Elevated temperature[3], Decreased activity4,

Decreased appetite4.

Very rare

(<1 animal / 10,000 animals treated, including isolated reports):

Hypersensitivity reactions5,

Immune mediated haemolytic anaemia, Immune mediated thrombocytopenia, Immune mediated polyarthritis.

1 ≤ 4 cm; subsides within 14 days.

2 Subsides within 14 days.

3 ≤ 1 °C, up to 3 days.

4 In pups.

5 Reactions are transient. This includes anaphylaxis (sometimes fatal). If such reaction occurs, appropriate treatment should be administered without delay.

Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or the national competent authority via the national reporting system. See also section 16 of the package leaflet for contact details.

Dispensing

POM-V - Prescription Only Medicine – Veterinarian
Dog
PRICE Only for registered vets. Create a free profile to access all features.. Login
Art. Nr. 01708/5030
EAN 8713184139641
PACKAGES
Canigen L4
Virbac
1 x 10 dose
01708/5030
Canigen L4
Virbac
1 x 50 dose
01708/5030
VETiSearch ApS - C.F. Richs Vej 99D - 2000 Copenhagen - Denmark - contact@vetisearch.co.uk - Legal registration number: 39926679
VETiSearch.co.uk Copyright © 2025 . All rights reserved. This information is intended only for residents of Great Britain. The product information provided on this site is intended only for residents of Great Britain. Products may have different product information in different countries.